ADX-914

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)NCT05509023QTTBPhase 2Active not recruiting2024-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.